Pancreatic Cystic Lesions
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions
AI-Powered Precision Decision-Making for Pancreatic Diseases
A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions
Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence
Graphic Novel for Patients Undergoing EUS-FNB
Evaluation of PCLs Using Three EUS-FNA Needles
Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy